EPISODE · Mar 17, 2022 · 10 MIN

Roflumilast (Daliresp) Pharmacology

from Real Life Pharmacology - Pharmacology Education for Health Care Professionals

On this episode I discuss roflumilast (Daliresp) pharmacology, adverse effects, and important drug interactions. Roflumilast is indicated to reduce the incidence of COPD exacerbations. Roflumilast is significantly broken down by CYP3A4 so there are numerous drug interactions that we have to take into account. Psychiatric issues, GI upset, and weight loss are all potential adverse effects due to roflumilast. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101

Episode metadata supplied by the publisher feed · Published Mar 17, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Roflumilast (Daliresp) Pharmacology

0:00 10:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Real Life Pharmacology - Pharmacology Education for Health Care Professionals?

This episode is 10 minutes long.

When was this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode published?

This episode was published on March 17, 2022.

Can I download this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!